Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

Completed · Phase 2

Conditions studied: HIV Infections, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Depression, Substance Abuse

In brief

This study will determine the effectiveness of the STIRR (Screen, Test, Immunize, Reduce risk, and Refer) intervention in increasing rates of testing, immunization, referral, and treatment for blood-borne diseases, such as hepatitis and HIV, in people with both a mental disorder and a substance abuse disorder.

Key facts

Study ID

NCT00316303

Run by

Dartmouth-Hitchcock Medical Center

People needed

236

Starts

2006-02-01

Expected to finish

2012-08-01

Last updated by the study team

2013-05-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• DSM-IV diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depression
• Diagnosis of a substance use disorder
• Enrolled in clinical care at Creative Alternatives or People Encouraging People for at least 3 months

You may not qualify if…

• Pregnant

Where it is running

• University of Maryland, Department of Psychaitry — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.